Pharmaceutical

Lupin announces US FDA approval and launch of Sugammade...

Global pharma major Lupin announced that following approval from the United Sta...

First Amgen Scholars Program in India launches at IIIT ...

Amgen announced the launch of the first Amgen Scholars Program in India at the ...

Arboreal raises ₹230 Crore Series A to scale India’s ne...

Arboreal Bioinnovations, India’s first specialty food and nutraceutical ingredi...

Synlogic and Caldera sign merger agreement

The companies will become 100%-owned subsidiaries of Caldera Therapeutics, a new...

Amgen’s Repatha receives positive CHMP opinion for broa...

Repatha is intended for adults with established or high risk of atherosclerotic ...

Biocon Foundation and IISc convene national experts to ...

The two-day conference brought together leading oncologists, clinicians, public...

Why clinical governance and doctor-led protocols are be...

Aesthetic medicine is no longer a boutique corner of healthcare. The Internatio...

RPG Life Sciences announces strategic API initiative to...

RPG Life Sciences announced the execution of a Business Transfer Agreement for ...

MRG Group announces strategic collaboration with Arica ...

MRG Group, a diversified business conglomerate, has announced its strategic col...

European Commission authorizes Pfizer and BioNTech XFG-...

Pfizer and BioNTech SE announced that the European Commission (EC) has granted ...

Sun Pharma receives approval to manufacture and market ...

Sun Pharmaceutical Industries announced that it has received approval from the ...

CureMeAbroad signs MoUs with Asia Cosmetics and Dr. Bre...

CureMeAbroad, a medical tourism discovery and concierge platform operated by Lu...

ChrysCapital completes acquisition of an Indian subsidi...

ChrysCapital, one of the biggest private equity firms investing in India, acqui...

FDA grants fast track designation for HAYA Therapeutics...

Targeting long non-coding ribonucleic acid (lncRNA), HTX-001 is being evaluated ...

Eisai and CORE Biomedicine agree on global licence for ...

The deal grants CORE Biomedicine rights to develop and commercialise a portfolio...

Bridging generics and specialty: A roadmap to complex m...

We keep telling ourselves the same story: India is the pharmacy of the world, a...